CLINICAL_TRIALS
trial_result
· 2021-03-16
Clinical Trial Update: Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer [Phase 3]
Summary
Phase 3 trial comparing docetaxel and ixabepilone in non-metastatic poor prognosis breast cancer; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UNICANCER | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-03-16